Sol H. Weiss

Sol H. Weiss is an American personal injury lawyer and Director of the Anapol Weiss law firm based in Philadelphia. Weiss has practiced law since 1972. He has secured many notable multimillion-dollar verdicts and settlements in national mass tort and class action litigations.
Verdicts and settlements
Co-Lead Counsel in NFL Players' Injury Litigation
Weiss serves as Co-Lead Counsel in the National Football League Players’ Concussion Injury Litigation, which reached a proposed settlement of $765 million to provide medical assistance to more than 18,000 former players suffering neurological problems. The litigation is presided over by Judge Anita B. Brody in the United States District Court for the Eastern District of Pennsylvania. The pending settlement awaits approval of the court. “When Weiss and others at the firm began to hear of NFL players suffering from chronic neurological damage, likely the result of repeated concussive collisions, they began to explore the possibility of suing the NFL on the premise that it had failed to protect the players' health,” the Philadelphia Inquirer reported. “Weiss said the firm consulted with neurosurgeons and scientists, reviewed the literature, and conferred with injured players.”
Regarding the case, Weiss was interviewed for the September 2013 edition of The Philadelphia Inquirer. In this article he emphasized that, "helmets can't protect you from all kinds of injuries.".
Products Liability Litigation
Weiss served as one of seven class counsel in the national Fen-Phen lawsuits titled In re: Diet Drugs (Phentermine, Fenfluramine, Dexfenfluramine) Products Liability Litigation. Plaintiffs in the lawsuit alleged the weight loss drugs caused valvular heart disease, an association that ultimately compelled the U.S. Food and Drug Administration to order fenfluramine and dexfenfluramine off the market in 1997. The lawsuit settled for $3.75 billion. Weiss was then referenced in a book titled Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic Story Behind the Battle over Fen-Phen about the complexities of the diet drug litigation.
Weiss also obtained a $68.5 million settlement for 168 people seriously injured by the statin drug Baycol in the multidistrict litigation (MDL) titled In re: Baycol Products Liability Litigation. Plaintiffs in the action claimed Baycol, which was commonly prescribed for high blood pressure and heart disease, caused a muscle damaging disease called rhabdomyolysis, kidney failure, and other injuries. Baycol was removed from the market in 2001.
Other past cases include the $17.75 million partial settlement in the Luzerne County Kids for cash litigation and the New Jersey consolidated Vioxx litigation. In addition to large and complex mass tort lawsuits, Weiss has litigated medical and professional malpractice, securities litigation and various product liability cases.
Honors and awards
He has been named in The Best Lawyers magazine annual list every year since 2006 and was featured on the cover of the 2011 edition of the publication.
Weiss was named to the Suburban Life reader's choice top attorneys in 2010.

Main Menu

See Also

Main Menu